Blog
RSS FeedPosted by Michael Wonder on 17 Jun 2023
Australian health insurers and pharmaceutical companies reckon with new psychedelic mental health treatments
17 June 2023 - Medicinal cannabis companies are trying to get a foothold in Australia's new psychedelics market, with therapies ...
Posted by Michael Wonder on 16 Jun 2023
Outcomes of the May 2023 PBAC intracycle meeting
16 June 2023 - The outcomes from the May 2023 PBAC intracycle meeting are now available. ...
Posted by Michael Wonder on 10 Jun 2023
Medical groups call on MPs to back 60 day prescribing as Labor backbench wobbles
10 June 2023 - A Coalition of peak medical groups has launched a campaign in support of 60 day prescribing ...
Posted by Michael Wonder on 09 Jun 2023
Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (June 2023)
9 June 2023 - The following documents are now available: ...
Posted by Michael Wonder on 07 Jun 2023
Calls for more medicinal cannabis brands to be added to Pharmaceutical Benefits Scheme as costs surge
8 June 2023 - Jukka Manttari is pain-free for the first time in 30 years thanks to medicinal cannabis, but ...
Posted by Michael Wonder on 05 Jun 2023
Aussies save almost $100 million on medicines in just five months
5 June 2023 - Australians have saved almost $100 million in just five months, off nearly 9 million prescriptions, thanks ...
Posted by Michael Wonder on 05 Jun 2023
New treatments for Australians with endometrial cancer and Lennox-Gastaut syndrome
5 June 2023 - From 1 June 2023, Australians with endometrial cancer and Lennox-Gastaut syndrome will have access to new ...
Posted by Michael Wonder on 01 Jun 2023
Mark Butler says Pharmacy Guild breached NDA, but chemists say they were given go ahead by government
1 June 2023 - The Pharmacy Guild says Health Minister Mark Butler’s chief of staff told it to “tell your ...
Posted by Michael Wonder on 01 Jun 2023
Antengene announces Xpovio plus bortezomib and dexamethasone included for reimbursement by the PBS in Australia for the treatment of relapsed and/or refractory multiple myeloma
31 May 2023 - This inclusion by the PBS for the treatment of patients with relapsed and/or refractory multiple myeloma who ...
Posted by Michael Wonder on 31 May 2023
RACGP opposes GLP-1 RA prescribing restrictions
30 May 2023 - Changing the authority type for initiating the diabetes medication will make it difficult for ‘already burdened’ GPs ...
Posted by Michael Wonder on 31 May 2023
Schedule of Pharmaceutical Benefits - 1 June 2023
1 June 2023 - The June 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 May 2023
Pharmacists crash Question Time as Albanese Government is slammed over 60 day PBS dispensing change
31 May 2023 - Question Time descended into chaos as Labor and the Coalition clashed over controversial changes to medical prescriptions ...
Posted by Michael Wonder on 25 May 2023
Australians battling with prostate cancer to benefit from new PBS listing
25 May 2023 - Australians battling prostate cancer that has spread past the prostate will soon benefit from subsidised medicine ...
Posted by Michael Wonder on 24 May 2023
PBAC Public Summary Document - May 2023
24 May 2023 - The Public Summary Document of the PBAC's consideration of the interim report of the post-market review of ...
Posted by Michael Wonder on 24 May 2023
New life changing treatment for dwarfism added to PBS
24 May 2023 - Children born with the most common form of dwarfism will have access to a new life ...